SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb. 1, 2006--The Affymetrix Microarray Bulletin (AMB) today published interviews with researchers from the University of Pennsylvania and the Scripps Research Institute who are using gene expression signatures to detect heart and kidney transplant rejection.
